CY1106783T1 - Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ - Google Patents
Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυInfo
- Publication number
- CY1106783T1 CY1106783T1 CY20071101027T CY071101027T CY1106783T1 CY 1106783 T1 CY1106783 T1 CY 1106783T1 CY 20071101027 T CY20071101027 T CY 20071101027T CY 071101027 T CY071101027 T CY 071101027T CY 1106783 T1 CY1106783 T1 CY 1106783T1
- Authority
- CY
- Cyprus
- Prior art keywords
- alleviating
- maintaining
- fatty acid
- deficiency conditions
- ecosidi
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 3
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 8
- 229940114079 arachidonic acid Drugs 0.000 abstract 4
- 235000021342 arachidonic acid Nutrition 0.000 abstract 4
- 230000007812 deficiency Effects 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 4
- 229930195729 fatty acid Natural products 0.000 abstract 4
- 239000000194 fatty acid Substances 0.000 abstract 4
- 150000004665 fatty acids Chemical class 0.000 abstract 4
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Μία νέα τεχνική για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή. Η χρησιμοποίηση υλικού που περιέχει DΡΑ για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και την διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή και συνθέσεων για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και την διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή, οι οποίες συνθέσεις περιέχουν DΡΑ-περιέχον υλικό σε μία ποσότητα αποτελεσματική στην ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή ανά μονάδα δόσεως.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5776999 | 1999-03-04 | ||
PCT/JP2000/001355 WO2000051444A1 (fr) | 1999-03-04 | 2000-03-06 | Utilisation d'une matiere contenant de l'acide docosapentaenoique |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106783T1 true CY1106783T1 (el) | 2012-05-23 |
Family
ID=13065097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071101027T CY1106783T1 (el) | 1999-03-04 | 2007-08-01 | Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ |
Country Status (13)
Country | Link |
---|---|
US (1) | US6596766B1 (el) |
EP (1) | EP1166652B2 (el) |
JP (1) | JP4518674B2 (el) |
KR (2) | KR100504324B1 (el) |
AT (1) | ATE361676T2 (el) |
AU (1) | AU766660C (el) |
CA (1) | CA2362515C (el) |
CY (1) | CY1106783T1 (el) |
DE (1) | DE60034775T3 (el) |
DK (1) | DK1166652T4 (el) |
ES (1) | ES2286999T5 (el) |
PT (1) | PT1166652E (el) |
WO (1) | WO2000051444A1 (el) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5340742A (en) * | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids |
US20060094089A1 (en) * | 1988-09-07 | 2006-05-04 | Martek Biosciences Corporation | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
KR20090064603A (ko) * | 2000-01-28 | 2009-06-19 | 마텍 바이오싸이언스스 코포레이션 | 발효기 내에서 진핵 미생물의 고밀도 배양에 의한 고도불포화 지방산을 함유하는 지질의 증진된 생산 방법 |
ATE510908T1 (de) | 2000-09-28 | 2011-06-15 | Bioriginal Food & Science Corp | Fad5-2, mitglied der desaturase-familie und verwendungen davon |
US7223434B2 (en) * | 2001-11-21 | 2007-05-29 | Gerber Products Company | Blended baby foods |
AU2002234611A1 (en) * | 2002-01-10 | 2003-07-24 | Puleva Biotech, S.A. | Oil blends |
ES2221576B1 (es) * | 2003-06-11 | 2006-03-16 | Puleva Biotech, S.A. | Mezclas de aceites. |
US8921422B2 (en) * | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
US7893106B2 (en) * | 2004-11-19 | 2011-02-22 | Martek Biosciences, Corporation | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same |
CN101102988B (zh) * | 2004-11-19 | 2011-12-14 | 马泰克生物科学公司 | 来自长链多不饱和脂肪酸的氧脂素及其制备和使用方法 |
US20090318394A1 (en) * | 2004-11-19 | 2009-12-24 | Julie Nauroth | Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
JP4893914B2 (ja) * | 2004-12-02 | 2012-03-07 | 公立大学法人島根県立大学 | 経管栄養組成物 |
DE102005003624A1 (de) * | 2005-01-26 | 2006-07-27 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Herstellung und Anwendung eines antioxidativ wirksamen Extraktes aus Crypthecodinium sp. |
ES2576986T3 (es) | 2005-06-07 | 2016-07-12 | Dsm Nutritional Products Ag | Microorganismos eucariotas para la producción de lípidos y antioxidantes |
KR20130101596A (ko) * | 2005-07-08 | 2013-09-13 | 마텍 바이오싸이언스스 코포레이션 | 치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산 |
WO2007058523A1 (en) * | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
US20090320148A1 (en) * | 2006-01-31 | 2009-12-24 | Martek Biosciences Corporation | Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same |
US9023616B2 (en) * | 2006-08-01 | 2015-05-05 | Dsm Nutritional Products Ag | Oil producing microbes and method of modification thereof |
SG10201501004UA (en) * | 2006-08-29 | 2015-04-29 | Dsm Ip Assets Bv | USE OF DPA(n-6) OILS IN INFANT FORMULA |
CN101663031A (zh) * | 2007-02-20 | 2010-03-03 | 马泰克生物科学公司 | 来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法 |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US20110027841A1 (en) * | 2007-12-21 | 2011-02-03 | Martek Biosciences Corporation | Method for preparation of oxylipins |
WO2009102558A2 (en) * | 2008-02-11 | 2009-08-20 | Monsanto Technology Llc | Aquaculture feed, products, and methods comprising beneficial fatty acids |
EP2145942A1 (de) * | 2008-07-15 | 2010-01-20 | Lonza Ltd. | Verfahren zur Isolierung von Ölen aus Zellen und Biomasse |
PL2334295T3 (pl) | 2008-09-02 | 2017-12-29 | Amarin Pharmaceuticals Ltd | Kompozycja farmaceutyczna zawierająca kwas eikozapentaenowy i kwas nikotynowy oraz sposoby jej zastosowania |
US8207363B2 (en) * | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
EP2424521A4 (en) | 2009-04-29 | 2015-03-04 | Amarin Pharmaceuticals Ie Ltd | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE |
CN102458109B (zh) | 2009-04-29 | 2015-02-11 | 阿马里纳制药公司 | 稳定的药物组合物和使用其的方法 |
KR102012111B1 (ko) | 2009-06-15 | 2019-08-19 | 아마린 파마, 인크. | 병용 스타틴 요법을 받는 대상체에서 ldl-c 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법 |
SG10201405994UA (en) | 2009-09-23 | 2014-10-30 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical Composition Comprising Omega-3 Fatty Acid And Hydroxy-derivative Of A Statin And Methods Of Using Same |
CN102884201B (zh) | 2010-01-19 | 2016-04-13 | 帝斯曼知识产权资产管理有限公司 | 生产二十碳五烯酸的微生物、脂肪酸组成物及其制作方法与用途 |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
NZ712068A (en) | 2010-11-29 | 2017-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
CN108771240A (zh) | 2011-07-21 | 2018-11-09 | 帝斯曼知识产权资产管理有限公司 | 脂肪酸组合物 |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
EP2775837A4 (en) | 2011-11-07 | 2015-10-28 | Amarin Pharmaceuticals Ie Ltd | METHODS OF TREATING HYPERTRIGLYCERIDEMIA |
WO2013103958A1 (en) | 2012-01-06 | 2013-07-11 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject |
SG11201408769QA (en) | 2012-06-29 | 2015-01-29 | Amarin Pharmaceuticals Ie Ltd | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
US8747916B1 (en) | 2012-10-30 | 2014-06-10 | Donald M. Smith | Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
AU2014229307B2 (en) | 2013-03-13 | 2017-08-31 | Dsm Nutritional Products Ag | Engineering microorganisms |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
EP3151679A4 (en) * | 2014-05-08 | 2017-12-20 | Donald M. Smith | Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
AR104042A1 (es) | 2015-03-26 | 2017-06-21 | Mara Renewables Corp | Producción de alta densidad de biomasa y aceite utilizando glicerol en bruto |
BR112018000690A2 (pt) | 2015-07-13 | 2018-09-18 | MARA Renewables Corporation | micro-organismo recombinante, e, métodos para preparar um micro-organismo de metabolização de xilose e para produzir óleo. |
WO2017055169A1 (en) * | 2015-10-01 | 2017-04-06 | Dsm Ip Assets B.V. | Supplement material for use in pet food |
CN105746908B (zh) * | 2016-02-23 | 2018-08-28 | 广州英赛特生物技术有限公司 | 肉豆蔻酸衍生物在制备动物生长促进剂中的应用 |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
TW201900160A (zh) | 2017-05-19 | 2019-01-01 | 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 | 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法 |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
KR102296068B1 (ko) | 2018-09-24 | 2021-09-02 | 애머린 파마슈티칼스 아일랜드 리미티드 | 대상체에서 심혈관 사건의 위험도를 감소시키는 방법 |
SG10201900614PA (en) * | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Maternal DPA for benefit of mother and/or child’s mental health |
JP7013619B2 (ja) * | 2019-12-26 | 2022-01-31 | マルハニチロ株式会社 | 多価不飽和脂肪酸が結合したリン脂質を含む魚卵脂質組成物 |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH075484B2 (ja) | 1985-03-06 | 1995-01-25 | 帝人株式会社 | 血液脳関門通過性医薬品組成物 |
US5444054A (en) | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
JP3627043B2 (ja) * | 1996-04-24 | 2005-03-09 | 明治乳業株式会社 | n−6系列/n−3系列脂肪酸バランス 改善ヌクレオチド含有乳児用食品 |
DK1785492T3 (da) * | 1996-07-23 | 2010-07-26 | Nagase Chemtex Corp | Fremgangsmåde til fremstilling af docosahexaensyre og docosapentaensyre |
JP3573595B2 (ja) * | 1997-05-30 | 2004-10-06 | 株式会社ベルリッチ | 高度不飽和脂肪酸及び/又はそのエステルを含有する組成物 |
-
2000
- 2000-03-06 US US09/914,897 patent/US6596766B1/en not_active Expired - Lifetime
- 2000-03-06 PT PT00906735T patent/PT1166652E/pt unknown
- 2000-03-06 DE DE60034775.3T patent/DE60034775T3/de not_active Expired - Lifetime
- 2000-03-06 ES ES00906735.6T patent/ES2286999T5/es not_active Expired - Lifetime
- 2000-03-06 KR KR10-2003-7017175A patent/KR100504324B1/ko active IP Right Grant
- 2000-03-06 KR KR10-2001-7011277A patent/KR100423013B1/ko active IP Right Grant
- 2000-03-06 JP JP2000601924A patent/JP4518674B2/ja not_active Expired - Lifetime
- 2000-03-06 AU AU28306/00A patent/AU766660C/en not_active Expired
- 2000-03-06 EP EP00906735.6A patent/EP1166652B2/en not_active Expired - Lifetime
- 2000-03-06 DK DK00906735.6T patent/DK1166652T4/en active
- 2000-03-06 WO PCT/JP2000/001355 patent/WO2000051444A1/ja active IP Right Grant
- 2000-03-06 CA CA002362515A patent/CA2362515C/en not_active Expired - Lifetime
- 2000-03-06 AT AT00906735T patent/ATE361676T2/de active
-
2007
- 2007-08-01 CY CY20071101027T patent/CY1106783T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60034775T2 (de) | 2008-01-17 |
PT1166652E (pt) | 2007-08-20 |
EP1166652B1 (en) | 2007-05-09 |
ATE361676T2 (de) | 2007-06-15 |
JP4518674B2 (ja) | 2010-08-04 |
DE60034775D1 (de) | 2007-06-21 |
AU766660C (en) | 2004-05-06 |
KR20040014597A (ko) | 2004-02-14 |
US6596766B1 (en) | 2003-07-22 |
KR100504324B1 (ko) | 2005-07-28 |
CA2362515A1 (en) | 2000-09-08 |
DE60034775T3 (de) | 2016-11-24 |
EP1166652A4 (en) | 2002-05-29 |
AU2830600A (en) | 2000-09-21 |
KR20010108311A (ko) | 2001-12-07 |
WO2000051444A1 (fr) | 2000-09-08 |
DK1166652T4 (en) | 2016-10-24 |
CA2362515C (en) | 2008-07-15 |
ES2286999T5 (es) | 2016-11-17 |
ES2286999T3 (es) | 2007-12-16 |
EP1166652B2 (en) | 2016-07-13 |
KR100423013B1 (ko) | 2004-03-12 |
DK1166652T3 (da) | 2007-09-10 |
AU766660B2 (en) | 2003-10-23 |
EP1166652A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106783T1 (el) | Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ | |
DE69902040D1 (de) | Zahnwiederherstellungsmaterial | |
CY1109626T1 (el) | Ενωσεις με ιδιοτητες αποδεσμευσης αυξητικης ορμονης | |
TR199901077A2 (en) | �spen�iyari form�lasyonlar. | |
BR9906888A (pt) | "travessa" | |
DE69828436D1 (de) | Radioaktive embolisierende zusammensetzungen | |
DE69817760D1 (de) | Polymerisierbare zusammensetzung für dentalanwendungen | |
DE69905363T2 (de) | Verpackung für zahnimplantat | |
DK1104425T3 (da) | Hidtil ukendte thiazolopyrimidinforbindelser | |
PT1185253E (pt) | Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac | |
ATE397922T1 (de) | Lipidspiegel modulation mit steroiden und ppar- alpha agonisten | |
DE60005423D1 (de) | Unterfütterungsmaterial für Zahnprothesen | |
SE9700934D0 (sv) | New formulation | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
ATE245028T1 (de) | Trimegestone enthaltende pharmazeutische zusammensetzungen | |
ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
DE60319871D1 (de) | Ausgabevorrichtung für einen behälter | |
ES2191625T3 (es) | Composicion oral que contiene perlita. | |
EA200000112A1 (ru) | Новая композиция | |
IL139144A0 (en) | Mycobacterial inhibitors | |
UA32598C2 (uk) | Спосіб одержання лікарської форми карбамазепіну | |
TR199802496T2 (xx) | Konjestif kalp yetmezli�ini tedavi i�in form�lasyon. | |
ATE418929T1 (de) | Austragvorrichtung für dentale zwecke | |
FR2795248B1 (fr) | Source monochromatique comprenant un materiau optiquement actif | |
NO20012169D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper |